These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9223523)

  • 1. Upregulation of human immunodeficiency virus (HIV) replication by CD4 cross-linking in peripheral blood mononuclear cells of HIV-infected adults.
    Than S; Oyaizu N; Tetali S; Romano J; Kaplan M; Pahwa S
    J Virol; 1997 Aug; 71(8):6230-2. PubMed ID: 9223523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 reactivation in resting peripheral blood mononuclear cells of infected adults upon in vitro CD4 cross-linking by ligands of the CDR2-loop in extracellular domain 1.
    Briant L; Reynes J; Coudronnière N; Benezech JP; Devaux C
    J Acquir Immune Defic Syndr; 1999 May; 21(1):9-19. PubMed ID: 10235509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
    J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
    Nokta MA; Li XD; Nichols J; Mallen M; Pou A; Asmuth D; Pollard RB
    AIDS; 2001 Jan; 15(2):161-9. PubMed ID: 11216923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells.
    Iyengar S; Hildreth JE; Schwartz DH
    J Virol; 1998 Jun; 72(6):5251-5. PubMed ID: 9573299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals.
    Oyaizu N; McCloskey TW; Coronesi M; Chirmule N; Kalyanaraman VS; Pahwa S
    Blood; 1993 Dec; 82(11):3392-400. PubMed ID: 7902137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
    Hashimoto K; Shigeta S; Baba M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent
    Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.
    Zhang T; Li Y; Wang YJ; Wang X; Young M; Douglas SD; Ho WZ
    Antiviral Res; 2007 Feb; 73(2):132-9. PubMed ID: 16997390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of latent human immunodeficiency virus infection on cell surface phenotype.
    Brooks DG; Zack JA
    J Virol; 2002 Feb; 76(4):1673-81. PubMed ID: 11799162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus.
    Lund N; Branch DR; Sakac D; Lingwood CA; Siatskas C; Robinson CJ; Brady RO; Medin JA
    AIDS; 2005 Sep; 19(14):1543-6. PubMed ID: 16135910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
    Yu J; Liang C; Liu SL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.
    Roth MD; Tashkin DP; Choi R; Jamieson BD; Zack JA; Baldwin GC
    J Infect Dis; 2002 Mar; 185(5):701-5. PubMed ID: 11865430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.
    Painter SL; Biek R; Holley DC; Poss M
    J Virol; 2003 Aug; 77(15):8448-61. PubMed ID: 12857914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs.
    Tan J; Wang X; Devadas K; Zhao J; Zhang P; Hewlett I
    J Cell Physiol; 2013 Dec; 228(12):2305-13. PubMed ID: 23696271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.
    Bam RA; Hansen D; Irrinki A; Mulato A; Jones GS; Hesselgesser J; Frey CR; Cihlar T; Yant SR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.
    Beaumont T; Broersen S; van Nuenen A; Huisman HG; de Roda Husman AM; Heeney JL; Schuitemaker H
    J Virol; 2000 Sep; 74(17):7699-707. PubMed ID: 10933675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and propagation of HIV-1 on peripheral blood mononuclear cells.
    van 't Wout AB; Schuitemaker H; Kootstra NA
    Nat Protoc; 2008; 3(3):363-70. PubMed ID: 18323807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs.
    Brozy J; Schlaepfer E; Mueller CKS; Rochat MA; Rampini SK; Myburgh R; Raum T; Kufer P; Baeuerle PA; Muenz M; Speck RF
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.